Abstract:Background: To investigate the mechanism of microRNA9 in inhibiting proliferation and migration of lung squamous cell carcinoma cells via neuron-restricted silencing factor/epidermal growth factor receptor. Material and Methods: Detection of microRNA9, neuron-restricted silencing factor, and epidermal growth factor receptor expression levels in lung cancer patients' tissues and lung cancer cells by Western blotting and quantitative polymerase chain reaction. Detection of cell proliferation by colony formation assay and cell counting kit-8 assay. Detection of cell migration by wound-healing assay and Transwell assay. And detection of the regulatory effect between neuron-restricted silencing factor and epidermal growth factor receptor by Luciferase reporter gene system. Subcutaneous implantation mouse models of NCI-H520 cells were constructed to detect cell proliferationin vivo, and Kaplan-Meier method calculated patient survival. Results: The expression of microRNA9 and epidermal growth factor receptor was higher in lung cancer tissues than in normal lung tissues, while the expression of neuron-restricted silencing factor was lower in lung cancer tissues than in normal lung tissues. MicroRNA9 higher expression was strongly related to tumor size, and TNM stage and predicted showed reduced overall survival in patients with lung cancer. Further loss of function and enhancement experiments revealed that inhibition of microRNA9 could significantly inhibit lung squamous carcinoma cell proliferation and migration. Luciferase reporter assay demonstrated that microRNA9 could bind to NRSF messenger RNA and inhibit its expression, neuron-restricted silencing factor overexpression also exerted inhibitory effects on cell proliferation and migration. Moreover, Luciferase reporter assay showed that neuron-restricted silencing factor downregulate epidermal growth factor receptor expression levels by binding to epidermal growth factor receptor promoter regions, and Pearson's correlation analysis indicated that the levels of microRNA9 in lung cancer tissues were correlated with neuron-restricted silencing factor and epidermal growth factor receptor. Combined microRNA9 with neuron-restricted silencing factor or epidermal growth factor receptor to predict the prognosis of patients with lung cancer may be more accurate. Conclusion: MicroRNA9 inhibits proliferation and migration of lung squamous cell carcinoma cells by inhibiting neuron-restricted silencing factor/epidermal growth factor receptor axis. MicroRNA9 can be a new prognostic marker and therapeutic target for lung squamous cell carcinoma.

miRNA-9 Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Regulating NRSF/EGFR.

MicroRNA-9 Regulates Non-Small Cell Lung Cancer Cell Invasion and Migration by Targeting Eukaryotic Translation Initiation Factor 5A2.

Microrna-148A-3p Inhibited the Proliferation and Epithelial-Mesenchymal Transition Progression of Non-Small-cell Lung Cancer Via Modulating Ras/MAPK/Erk Signaling

MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.

MiR‐372‐3p Promotes Cell Growth and Metastasis by Targeting FGF9 in Lung Squamous Cell Carcinoma

Analysis of Genetic Variants and the Cerna Network of Mir-9 in Non-Small Cell Lung Cancer

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking

Microrna-9 Inhibits the Proliferation and Migration of Malignant Melanoma Cells Via Targeting Sirituin 1

miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)

MicroRNA-9 Suppresses the Growth, Migration, and Invasion of Malignant Melanoma Cells Via Targeting NRP1

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer

MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9

KLF9 Regulates Mir-338-3p/nrcam Axis to Block the Progression of Osteosarcoma Cells

Mir-9 Targets CXCR4 and Functions As a Potential Tumor Suppressor in Nasopharyngeal Carcinoma.

MicroRNA-9 Inhibits the Proliferation of Oral Squamous Cell Carcinoma Cells by Suppressing Expression of CXCR4 Via the Wnt/β-catenin Signaling Pathway

Mir-592 Functions As a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Targeting SOX9.

MicroRNA-9 Enhanced Radiosensitivity and Its Mechanism of DNA Methylation in Non-Small Cell Lung Cancer

Oncogenic miR-9 is a target of erlotinib in NSCLCs

Microrna-99A is Downregulated and Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer A549 and H1299 Cells.

Downregulation of miR-499a-5p Predicts a Poor Prognosis of Patients With Non-Small Cell Lung Cancer and Restrains the Tumorigenesis by Targeting Fibroblast Growth Factor 9